|
|
|
Max Delbrück Center for Molecular Medicine (MDC), Berlin-Buch Campus
|
Robert Rössle Str. 10, 13125 Berlin
|
|
|
Scientific chairman:
|
|
|
Prof. Dr. Walter Rosenthal |
|
|
(030) 9406 0 |
|
|
(030) 949 4161
|
|
|
info@mdc-berlin.de |
|
|
www.mdc-berlin.de |
|
Sponsor:
|
Berlin Region and Federal Government |
|
|
 |
| Profile: The Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch is engaged in the latest biomedical and clinical research. MDC scientists are applying molecular biological and gene technology methods to discover the genetic origins of complex diseases such as cancer or high blood pressure and are using this information to develop more effective strategies to combat these serious conditions. |
|
| With the help of molecular biological methods, they are engaged in the investigation of complex diseases like cancer, cardiovascular conditions and diseases of the nervous system and are developing scientifically-based procedures for their diagnosis, treatment and prevention. MDC scientists are working in close collaboration with the clinicians of the Charité at the Experimental and clinical Research Center as well as the biotech companies that are located on the Campus. |
|
Prof. Dr. Walter Rosenthal
|
 |
Leibniz Institute for Molecular Pharmacology (German abbrev. FMP), Berlin-Buch Campus
|
Robert Rössle Str. 10, 13125 Berlin
|
|
|
Acting Director:
|
|
|
Prof. Dr. Hartmut Oschkinat |
|
|
(030) 94793-100 |
|
|
(030) 94793-109
|
|
|
direktor@fmp-berlin.de |
|
|
www.fmp-berlin.de |
|
Sponsor:
|
Berlin Region and Federal Government |
|
|
|
| Profil: Since 2000 the Leibniz Institute for Molecular Pharmacology has also been located on the Berlin-Buch Campus. It is engaged in basic research to identify and apply potential target structures for therapeutic ends. The interdisciplinary research is based on collaboration on specific topics and on-site cooperation between physicians, molecular biologists, molecular geneticists, structural biologists and chemists. |
|
|
The aim is the development of new concepts to produce a pharmacological effect on the body. A wide variety of cooperative links with national and international universities, non-university research facilities and business has led to a variety of new developments. The institute was created in 1992 from the Institute for Active Products Research of the GDR Academy of Sciences and empolys ca. 190 staff.
|
|
|
|
|
